Harvard Bioscience (HBIO) Cash & Equivalents Growth (3y) (2013 - 2026)
Harvard Bioscience (HBIO) Cash & Equivalents Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -7.03% |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -25.69% |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 21.08% |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 93.87% |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -18.20% |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | - |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 7.45% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 8.39% |
| 10 | Harvard Bioscience | 26.75 Mn | 19.65 Mn | 12.24 Mn | 23.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.27% |
| Dec 31, 2025 | 24.09% |
| Sep 30, 2025 | 9.84% |
| Jun 30, 2025 | 20.45% |
| Mar 31, 2025 | 0.69% |
| Dec 31, 2024 | -19.32% |
| Sep 30, 2024 | -6.27% |
| Jun 30, 2024 | -13.42% |
| Mar 31, 2024 | -9.89% |
| Dec 31, 2023 | -19.85% |
| Sep 30, 2023 | 23.92% |
| Jun 30, 2023 | 18.04% |
| Mar 31, 2023 | -13.64% |
| Dec 31, 2022 | -18.52% |
| Sep 30, 2022 | -9.08% |
| Jun 30, 2022 | -4.79% |
| Mar 31, 2022 | 2.60% |
| Dec 31, 2021 | -1.46% |
| Sep 30, 2021 | -5.91% |
| Jun 30, 2021 | 3.51% |